Your browser doesn't support javascript.
loading
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors.
Hengel, Holger; Martus, Peter; Faber, Jennifer; Giunit, Paola; Garcia-Moreno, Hector; Solanky, Nita; Klockgether, Thomas; Reetz, Kathrin; van de Warrenburg, Bart P; Santana, Magda M; Silva, Patrick; Cunha, Inês; de Almeida, Luís Pereira; Timmann, Dagmar; Infante, Jon; de Vries, Jeroen; Lima, Manuela; Pires, Paula; Bushara, Khalaf; Jacobi, Heike; Onyike, Chiadi; Schmahmann, Jeremy D; Hübener-Schmid, Jeannette; Synofzik, Matthis; Schöls, Ludger.
Afiliação
  • Hengel H; Department of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, 72076, Tübingen, Germany.
  • Martus P; German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
  • Faber J; Institute of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany.
  • Giunit P; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Garcia-Moreno H; Department of Neurology, University Hospital Bonn, Bonn, Germany.
  • Solanky N; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Klockgether T; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
  • Reetz K; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • van de Warrenburg BP; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
  • Santana MM; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Silva P; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
  • Cunha I; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • de Almeida LP; Department of Neurology, University Hospital Bonn, Bonn, Germany.
  • Timmann D; Department of Neurology, RWTH Aachen University, Aachen, Germany.
  • Infante J; JARA-Brain Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich, Jülich, Germany.
  • de Vries J; Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Lima M; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.
  • Pires P; Center for Innovation in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.
  • Bushara K; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.
  • Jacobi H; Center for Innovation in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.
  • Onyike C; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
  • Schmahmann JD; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.
  • Hübener-Schmid J; Center for Innovation in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.
  • Synofzik M; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.
  • Schöls L; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
J Neurol ; 270(2): 944-952, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36324033
ABSTRACT

BACKGROUND:

Non-motor symptoms (NMS) are a substantial burden for patients with SCA3. There are limited data on their frequency, and their relation with disease severity and activities of daily living is not clear. In addition, lifestyle may either influence or be affected by the occurrence of NMS.

OBJECTIVE:

To characterize NMS in SCA3 and investigate possible associations with disease severity and lifestyle factors.

METHODS:

In a prospective cohort study, we performed a cross-sectional analysis of NMS in 227 SCA3 patients, 42 pre-ataxic mutation carriers, and 112 controls and tested for associations with SARA score, activities of daily living, and the lifestyle factors alcohol consumption, smoking and physical activity.

RESULTS:

Sleep disturbance, restless legs syndrome, mild cognitive impairment, depression, bladder dysfunction and pallhypesthesia were frequent among SCA3 patients, while mainly absent in pre-ataxic mutation carriers. Except for restless legs syndrome, NMS correlated significantly with disease severity and activities of daily living. Alcohol abstinence was associated with bladder dysfunction. Patients with higher physical activity showed less cognitive impairment and fewer depressive symptoms, but these differences were not significant.

CONCLUSION:

This study revealed a clear association between disease severity and NMS, likely driven by the progression of the widespread neurodegenerative process. Associations between lifestyle and NMS can probably be attributed to the influence of NMS on lifestyle.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome das Pernas Inquietas Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome das Pernas Inquietas Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article